Valuation: AstraZeneca PLC

Market Cap 26TCr 3,83,04800Cr 22TCr 20TCr 19TCr 35TCr 24,47400Cr 36TCr 2,42400Cr 94TCr 12,26500Cr 96TCr 94TCr 40,60600Cr P/E 2026 *
21.1x
P/E 2027 * 18.4x
Enterprise Value 28TCr 4,11,99100Cr 24TCr 22TCr 20TCr 38TCr 26,32300Cr 39TCr 2,60700Cr 1,01600Cr 13,19200Cr 1,03300Cr 1,01000Cr 43,67400Cr EV / Sales 2026 *
4.35x
EV / Sales 2027 * 4x
Free-Float
96.63%
Yield 2026 *
2.02%
Yield 2027 * 2.14%
1 day+0.35%
1 week+5.11%
Current month-2.43%
1 month+1.00%
3 months-6.21%
6 months-12.19%
Current year-7.37%
1 week 62,800
Extreme 62800
65,625
1 month 60,650
Extreme 60650
69,800
Current year 60,650
Extreme 60650
80,275
1 year 50,650
Extreme 50650
80,275
3 years 24,182
Extreme 24182
80,275
5 years 4,889
Extreme 4889
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%+5.11% - - 25TCr
-2.81%+2.93%+76.40%+127.73% 1,14100Cr
-2.21%+2.02%+49.50%+55.01% 66TCr
-1.56%+4.39%+25.19%+74.39% 47TCr
+1.20%+2.62%+41.69%+45.78% 37TCr
-0.61%+2.10%+23.43%+41.34% 30TCr
+0.32%+3.25%+0.94%+13.42% 25TCr
-1.95%+3.80%+46.31%+65.66% 24TCr
-1.10%-0.70%-14.31%-52.66% 21TCr
-2.82%+3.84%+20.81%+89.04% 18TCr
Average -1.12%+2.87%+30.00%+51.08% 42.46TCr
Weighted average by Cap. -1.52%+3.12%+43.48%+70.86%

Financials

2026 *2027 *
Net sales 6.32TCr 94,71900Cr 5.42TCr 5.05TCr 4.64TCr 8.71TCr 6,05200Cr 8.88TCr 60TCr 23TCr 3,03300Cr 24TCr 23TCr 10,04100Cr 6.68TCr 1,00,09600Cr 5.72TCr 5.34TCr 4.9TCr 9.21TCr 6,39500Cr 9.39TCr 63TCr 25TCr 3,20500Cr 25TCr 25TCr 10,61100Cr
Net income 1.21TCr 18,07600Cr 1.03TCr 964.22Cr 884.76Cr 1.66TCr 1,15500Cr 1.7TCr 11TCr 4.46TCr 58TCr 4.53TCr 4.43TCr 1,91600Cr 1.37TCr 20,54000Cr 1.17TCr 1.1TCr 1.01TCr 1.89TCr 1,31200Cr 1.93TCr 13TCr 5.07TCr 66TCr 5.15TCr 5.04TCr 2,17700Cr
Net Debt 1.93TCr 28,94300Cr 1.65TCr 1.54TCr 1.42TCr 2.66TCr 1,84900Cr 2.71TCr 18TCr 7.14TCr 93TCr 7.26TCr 7.1TCr 3,06800Cr 1.17TCr 17,45000Cr 997.65Cr 930.83Cr 854.12Cr 1.6TCr 1,11500Cr 1.64TCr 11TCr 4.3TCr 56TCr 4.38TCr 4.28TCr 1,85000Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
20/26/20 ARS 65,350.00 +0.35% 4,619
19/26/19 ARS 65,125.00 +3.01% 4,014
18/26/18 ARS 63,225.00 +2.72% 1,963
14/26/14 ARS 61,550.00 -1.01% 300
13/26/13 ARS 62,175.00 -1.07% 628
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
164.91USD
Average target price
212.30USD
Spread / Average Target
+28.74%

Quarterly revenue - Rate of surprise